![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
SP Berger, K Farrell, D Conant, ES Kempner and SM Paul
Laboratory of Psychiatry and Neurology, University of California, San Francisco/San Francisco Veterans Administration Medical Center 94121.
Using radiation inactivation, we have estimated the target size for the neuronal dopamine transporter protein. The specific binding of several radioligands previously shown to label the dopamine transporter was determined in an irradiated striatal membrane preparation. The apparent target size of the 1-[1-(2-[3H]benzo[b]thienyl)cyclohexyl]piperidine site was approximately 98 kDa. However, the apparent target size of the "cocaine binding site," as measured with the cocaine analogue 2 beta- [3H]carbomethoxy-3 beta-(4-fluorophenyl)tropane in the same assays, was approximately 140 kDa. Radiation inactivation of the binding of other ligands (GBR-12935 and mazindol) led to target size estimates in the same range (94 kDa and 133 kDa, respectively). All of these target sizes are significantly larger than the estimate of 70 kDa derived from the deduced amino acid sequence for the cloned dopamine reuptake transporter cDNA. Larger target sizes than expected have also been reported for ligand binding to the sodium-dependent serotonin transporter and glucose transporter. The estimated sizes for the ligand binding site(s) associated with the dopamine transporter protein are difficult to reconcile with a single transporter protein of 70 kDa. We conclude that the dopamine transporter protein is a homo- or hetero- oligomer when occupied in situ by uptake-blocking drugs like cocaine.
This article has been cited by other articles:
|
|
 |
|
  A. J. Baucum II, K. S. Rau, E. L. Riddle, G. R. Hanson, and A. E. Fleckenstein Methamphetamine Increases Dopamine Transporter Higher Molecular Weight Complex Formation via a Dopamine- and Hyperthermia-Associated Mechanism J. Neurosci., March 31, 2004; 24(13): 3436 - 3443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Sitte, H. Farhan, and J. A. Javitch Sodium-Dependent Neurotransmitter TRANSPORTERS: OLIGOMERIZATION as a Determinant of Transporter Function and Trafficking Mol. Interv., February 1, 2004; 4(1): 38 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Ozaslan, S. Wang, B. A. Ahmed, A. M. Kocabas, J. C. McCastlain, A. Bene, and F. Kilic Glycosyl Modification Facilitates Homo- and Hetero-oligomerization of the Serotonin Transporter: A SPECIFIC ROLE FOR SIALIC ACID RESIDUES J. Biol. Chem., November 7, 2003; 278(45): 43991 - 44000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Sorkina, S. Doolen, E. Galperin, N. R. Zahniser, and A. Sorkin Oligomerization of Dopamine Transporters Visualized in Living Cells by Fluorescence Resonance Energy Transfer Microscopy J. Biol. Chem., July 18, 2003; 278(30): 28274 - 28283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. S. Ramsey and L. J. DeFelice Serotonin Transporter Function and Pharmacology Are Sensitive to Expression Level. EVIDENCE FOR AN ENDOGENOUS REGULATORY FACTOR J. Biol. Chem., April 19, 2002; 277(17): 14475 - 14482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hastrup, A. Karlin, and J. A. Javitch Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment PNAS, August 28, 2001; 98(18): 10055 - 10060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Haugeto, K. Ullensvang, L. M. Levy, F. A. Chaudhry, T. Honore, M. Nielsen, K. P. Lehre, and N. C. Danbolt Brain Glutamate Transporter Proteins Form Homomultimers J. Biol. Chem., November 1, 1996; 271(44): 27715 - 27722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J.S. Lee, Z. B. Pristupa, B. J. Ciliax, A. I. Levey, and H. B. Niznik The Dopamine Transporter Carboxyl-terminal Tail. TRUNCATION/SUBSTITUTION MUTANTS SELECTIVELY CONFER HIGH AFFINITY DOPAMINE UPTAKE WHILE ATTENUATING RECOGNITION OF THE LIGAND BINDING DOMAIN J. Biol. Chem., August 23, 1996; 271(34): 20885 - 20894. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Amara Monoamine Transporters: Basic Biology with Clinical Implications Neuroscientist, September 1, 1995; 1(5): 259 - 267. [Abstract] [PDF]
|
|
|
|
|
|
C. Roubert, P. J. Cox, M. Bruss, M. Hamon, H. Bonisch, and B. Giros Determination of Residues in the Norepinephrine Transporter That Are Critical for Tricyclic Antidepressant Affinity J. Biol. Chem., March 9, 2001; 276(11): 8254 - 8260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Kilic and G. Rudnick Oligomerization of serotonin transporter and its functional consequences PNAS, March 28, 2000; 97(7): 3106 - 3111. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
